Lv11
10 积分 2024-01-24 加入
Rat-to-human PBPK model of U-47700: Unveiling pharmacokinetic risks of a synthetic opioid through interspecies extrapolation
7小时前
待确认
Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: Case example diclofenac
6天前
已完结
Predicting the Efficacy of an Oral Paclitaxel Formulation (DHP107) Through Modeling and Simulation
1个月前
已完结
Comparison of the Pharmacokinetics of Subcutaneous Ustekinumab between Chinese and Non-Chinese Healthy Male Subjects across Two Phase 1 Studies
1个月前
已完结
Model-based evaluation of the impact of formulation and food intake on the complex oral absorption of mavoglurant in healthy subjects
1个月前
已完结
Mechanistic understanding of underperforming enteric coated products: Opportunities to add clinical relevance to the dissolution test
1个月前
已完结
Physiologically Based Biopharmaceutics Modeling Coupled with Biopredictive Dissolution in Development of Bioequivalent Formulation for Mesalamine Enteric Coated Tablet: A Tough Nut to Crack
1个月前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia: A Phase 2 Study
1个月前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
1个月前
已完结
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
1个月前
已完结
皖公网安备34019202002308
